Drug Companies Impacted By Biden Rx Cost Saving Effort Boasted Of $38.7b In Profits In 2022

A recent analysis found some of the major pharma companies that produce the affected, notoriously expensive drugs reported combined earnings of $38.7 billion.

Related Keywords

Washington ,United States ,United Kingdom ,American ,Eli Lilly ,Tony Carrk ,America Ph ,Johnson Janssen ,Astrazeneca ,Human Services ,Their Allies In Congress ,Us Department Of Health ,Big Drug Companies ,Inflation Reduction Act ,Big Pharma ,Executive Director ,Inflation Reduction ,Drug Companies ,Their Allies ,Congress Will Say ,Keep Drug Prices Unaffordable ,Pharmaceutical Research ,